Episode

New Myostatin Blocker Omega-3 News

Podcast: Iron Radio-Nutrition Radio Network
Published: Jul 6, 2026
Duration seconds: 2192
Processing state: not_requested
Canonical source: https://www.newassociates.org/
Audio: https://cdn.simplecast.com/media/audio/transcoded/53e3d261-c5f9-44f9-a22d-bab6ffed6551/0455b8f0-adb3-4bf1-bd82-3a2468c51d0b/episodes/audio/group/12b9e62a-d923-4237-b43d-b982bff19966/group-item/d6777211-1a74-4f9b-8916-f10c044c303f/128_default_tc.mp3?aid=rss_feed&feed=Ar_bYLxm
JSON: /v1/public/podcasts/iron-radio-nutrition-radio-network-5984590/episodes/new-myostatin-blocker-omega-3-news
Markdown: /podcast/iron-radio-nutrition-radio-network-5984590/new-myostatin-blocker-omega-3-news.md

Actions

POST https://stenobird.com/v1/public/podcasts/iron-radio-nutrition-radio-network-5984590/episodes/new-myostatin-blocker-omega-3-news/transcription-requests
Idempotently request low-priority transcript generation for this episode.
GET https://stenobird.com/podcast/iron-radio-nutrition-radio-network-5984590/new-myostatin-blocker-omega-3-news.md
Read the agent-friendly Markdown representation of this episode resource.

Summary

In this Iron Radio episode, hosts Coach Phil Stevens, Dr. Mike T. Nelson, and Dr. Lonnie Lowery discuss a newly circulated myostatin-blocking drug, Trevogrumab, covering its potential for extreme muscle gain and the significant safety risks including deaths reported in early trials. The conversation shifts to an Omega-3 news article questioning fish oil value, with the hosts contextualizing the preclinical research and sharing their own testing practices and supplementation rationale.